NinePointTwo Capital »

Intellia Therapeutics shares owned by NinePointTwo Capital

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by NinePointTwo Capital from 13F filings

Historical chart of NinePointTwo Capital investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by NinePointTwo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by NinePointTwo Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $370k 12k 30.46
2023-06-30 $251k 6.2k 40.64

More positions owned by NinePointTwo Capital

Schwab Strategic Tr Us Tips Etf (SCHP)
Vaneck Etf Trust Jp Mrgan Em Loc (EMLC)
Ishares Tr Tips Bd Etf (TIP)
Dbx Etf Tr Xtrack Usd High (HYLB)
Vanguard Whitehall Fds High Div Yld (VYM)
Invesco Actvely Mngd Etc Optimum Yield (PDBC)
Ishares Tr Select Divid Etf (DVY)
Apollo Global Mgmt (APO)
Ishares Tr Rus Tp200 Gr Etf (IWY)
Apple (AAPL)
Hca Holdings (HCA)
Microsoft Corporation (MSFT)
UnitedHealth (UNH)
Meta Platforms Cl A (META)
Nxp Semiconductors N V (NXPI)

View all positions for NinePointTwo Capital

Top funds holding Intellia Therapeutics

ARK Investment Management
Vanguard Group
BlackRock
Contrarius Group Holdings
State Street Corporation
Goldman Sachs Group
Morgan Stanley
Regeneron Pharmaceuticals
Baker Bros. Advisors
Geode Capital Management
Two Sigma Investments
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
D. E. Shaw & Co
Two Sigma Advisers

View all funds holding Intellia Therapeutics